THE LATEST FROM MiRus

MoRe® News

Unconditional FDA Approval of the STAR Trial (Siegel Transcatheter Aortic Valve Replacement in patients with symptomatic severe aortic stenosis)

11/25/2025

MiRus receives unconditional FDA approval for the STAR Trial RCT of the Siegel TAVR.

Scroll to Top